PE20000633A1 - Combinaciones terapeuticas para la fragilidad musculoesqueletica - Google Patents
Combinaciones terapeuticas para la fragilidad musculoesqueleticaInfo
- Publication number
- PE20000633A1 PE20000633A1 PE1999000522A PE00052299A PE20000633A1 PE 20000633 A1 PE20000633 A1 PE 20000633A1 PE 1999000522 A PE1999000522 A PE 1999000522A PE 00052299 A PE00052299 A PE 00052299A PE 20000633 A1 PE20000633 A1 PE 20000633A1
- Authority
- PE
- Peru
- Prior art keywords
- etil
- pyridin
- oxo
- tartrate
- salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE a)UN MODULADOR SELECTIVO DEL RECEPTOR DE ESTROGENOS (SERM) TAL COMO (-)-CIS-6-FENIL-5-(4-(2-PIRROLIDIN-1-IL-ETOXI)-FENIL)-5,6,7,8-TETRAHIDRONAFTALENO-2-OL O SU SAL D-TARTRATO; b)UN SECRETAGOGO DE LA HORMONA DE CRECIMIENTO TAL COMO 2-AMINO-N-(1(R)-(2,4-DIFLUORO-BENCILOXIMETIL)-2-OXO-2-(3-OXO-3a(R)-PIRIDIN-2-ILMETIL)-2-(2,2,2-TRIFLUORO-ETIL)-2,3,3a,4,6,7-HEXAHIDRO-PIRAZOLO[4,3-c]PIRIDIN-5-IL)-ETIL)-2-METIL-PROPIONAMIDA O SU SAL L-TARTRATO. LA COMPOSICION PUEDE SER UTIL PARA EL TRATAMIENTO DE LA FRAGILIDAD MUSCULOESQUELETICA, OSTEOPOROSIS, OSTEOTOMIA, PERDIDA OSEA IDIOPATICA INFANTIL, PERDIDA OSEA ASOCIADA CON PERIODONTITIS, CURACION DE HUESO DESPUES DE UNA RECONSTRUCCION FACIAL, RECONSTRUCCION MAXILAR, RECONSTRUCCION MANDIBULAR
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8942498P | 1998-06-16 | 1998-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20000633A1 true PE20000633A1 (es) | 2000-07-26 |
Family
ID=22217565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000522A PE20000633A1 (es) | 1998-06-16 | 1999-06-11 | Combinaciones terapeuticas para la fragilidad musculoesqueletica |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP1085867A1 (es) |
| JP (1) | JP2002518328A (es) |
| KR (1) | KR20010052817A (es) |
| CN (1) | CN1305378A (es) |
| AP (1) | AP9901581A0 (es) |
| AR (1) | AR018868A1 (es) |
| AU (1) | AU3342099A (es) |
| BG (1) | BG105128A (es) |
| BR (1) | BR9911357A (es) |
| CA (1) | CA2335112A1 (es) |
| CO (1) | CO5070586A1 (es) |
| EA (1) | EA200001189A1 (es) |
| GT (1) | GT199900083A (es) |
| HR (1) | HRP20000857A2 (es) |
| HU (1) | HUP0102395A2 (es) |
| ID (1) | ID26726A (es) |
| IL (1) | IL139587A0 (es) |
| IS (1) | IS5727A (es) |
| MA (1) | MA26648A1 (es) |
| NO (1) | NO20006381D0 (es) |
| OA (1) | OA11569A (es) |
| PA (1) | PA8472101A1 (es) |
| PE (1) | PE20000633A1 (es) |
| PL (1) | PL345064A1 (es) |
| SK (1) | SK18902000A3 (es) |
| TN (1) | TNSN99118A1 (es) |
| UY (1) | UY25557A1 (es) |
| WO (1) | WO1999065488A1 (es) |
| ZA (1) | ZA993973B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1004306A3 (en) * | 1998-08-06 | 2000-06-07 | Pfizer Products Inc. | Estrogen agonists/antagonists |
| IL145106A0 (en) * | 2000-08-30 | 2002-06-30 | Pfizer Prod Inc | Intermittent administration of a geowth hormone secretagogue |
| CA2420535A1 (en) * | 2000-08-30 | 2002-03-07 | Mary Tanya Am Ende | Sustained release formulations for growth hormone secretagogues |
| US7524866B2 (en) | 2001-11-29 | 2009-04-28 | Gtx, Inc. | Prevention and treatment of androgen—deprivation induced osteoporosis |
| DK1460969T3 (da) * | 2001-11-29 | 2008-09-01 | Gtx Inc | Forebyggelse og behandling af ved androgen-berövelse fremkaldt osteoporose |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
| EP2118080B1 (en) | 2007-02-09 | 2016-08-31 | Ocera Therapeutics, Inc. | Macrocyclic ghrelin receptor modulators and methods of using the same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA51676C2 (uk) * | 1995-11-02 | 2002-12-16 | Пфайзер Інк. | (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція |
| TW432073B (en) * | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| HN1996000101A (es) * | 1996-02-28 | 1997-06-26 | Inc Pfizer | Terapia combinada para la osteoporosis |
-
1999
- 1999-05-03 EP EP99914723A patent/EP1085867A1/en not_active Withdrawn
- 1999-05-03 CN CN99807381A patent/CN1305378A/zh active Pending
- 1999-05-03 HU HU0102395A patent/HUP0102395A2/hu unknown
- 1999-05-03 ID IDW20002604A patent/ID26726A/id unknown
- 1999-05-03 OA OA1200000346A patent/OA11569A/en unknown
- 1999-05-03 JP JP2000554368A patent/JP2002518328A/ja active Pending
- 1999-05-03 KR KR1020007014140A patent/KR20010052817A/ko not_active Application Discontinuation
- 1999-05-03 EA EA200001189A patent/EA200001189A1/ru unknown
- 1999-05-03 AU AU33420/99A patent/AU3342099A/en not_active Abandoned
- 1999-05-03 PL PL99345064A patent/PL345064A1/xx unknown
- 1999-05-03 BR BR9911357-0A patent/BR9911357A/pt not_active Application Discontinuation
- 1999-05-03 IL IL13958799A patent/IL139587A0/xx unknown
- 1999-05-03 SK SK1890-2000A patent/SK18902000A3/sk unknown
- 1999-05-03 CA CA002335112A patent/CA2335112A1/en not_active Abandoned
- 1999-05-03 WO PCT/IB1999/000796 patent/WO1999065488A1/en not_active Application Discontinuation
- 1999-05-07 PA PA19998472101A patent/PA8472101A1/es unknown
- 1999-06-10 AP APAP/P/1999/001581A patent/AP9901581A0/en unknown
- 1999-06-11 PE PE1999000522A patent/PE20000633A1/es not_active Application Discontinuation
- 1999-06-11 UY UY25557A patent/UY25557A1/es not_active Application Discontinuation
- 1999-06-14 GT GT199900083A patent/GT199900083A/es unknown
- 1999-06-15 AR ARP990102847A patent/AR018868A1/es not_active Application Discontinuation
- 1999-06-15 ZA ZA9903973A patent/ZA993973B/xx unknown
- 1999-06-15 MA MA25622A patent/MA26648A1/fr unknown
- 1999-06-15 TN TNTNSN99118A patent/TNSN99118A1/fr unknown
- 1999-06-16 CO CO99037624A patent/CO5070586A1/es unknown
-
2000
- 2000-11-24 IS IS5727A patent/IS5727A/is unknown
- 2000-12-14 HR HR20000857A patent/HRP20000857A2/hr not_active Application Discontinuation
- 2000-12-14 NO NO20006381A patent/NO20006381D0/no not_active Application Discontinuation
-
2001
- 2001-01-08 BG BG105128A patent/BG105128A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AP9901581A0 (en) | 1999-06-30 |
| CN1305378A (zh) | 2001-07-25 |
| EP1085867A1 (en) | 2001-03-28 |
| CO5070586A1 (es) | 2001-08-28 |
| BR9911357A (pt) | 2001-03-13 |
| HUP0102395A2 (hu) | 2001-11-28 |
| AR018868A1 (es) | 2001-12-12 |
| AU3342099A (en) | 2000-01-05 |
| ID26726A (id) | 2001-02-01 |
| HRP20000857A2 (en) | 2001-10-31 |
| OA11569A (en) | 2004-07-01 |
| IL139587A0 (en) | 2002-02-10 |
| UY25557A1 (es) | 2001-01-31 |
| EA200001189A1 (ru) | 2001-06-25 |
| NO20006381L (no) | 2000-12-14 |
| PL345064A1 (en) | 2001-11-19 |
| CA2335112A1 (en) | 1999-12-23 |
| GT199900083A (es) | 2000-12-05 |
| PA8472101A1 (es) | 2000-09-29 |
| JP2002518328A (ja) | 2002-06-25 |
| TNSN99118A1 (fr) | 2005-11-10 |
| SK18902000A3 (sk) | 2001-12-03 |
| KR20010052817A (ko) | 2001-06-25 |
| WO1999065488A1 (en) | 1999-12-23 |
| BG105128A (en) | 2001-11-30 |
| IS5727A (is) | 2000-11-24 |
| ZA993973B (en) | 2000-12-15 |
| MA26648A1 (fr) | 2004-12-20 |
| NO20006381D0 (no) | 2000-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP066313A (es) | Derivados de la piridazina y su uso como agentes terapéuticos | |
| ECSP066315A (es) | Derivados de la piridazina y su uso como agentes terapéuticos | |
| AR023130A1 (es) | Composiciones para promover el crecimiento | |
| IL154888A (en) | Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid | |
| DE69727158D1 (de) | Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien | |
| PA8493701A1 (es) | Compuestos para tratar la obesidad | |
| NO20022442L (no) | Legemidler for sykdommer i forbindelse med reduksjon i benmasse | |
| ATE112684T1 (de) | Verwendung von igf-ii zur behandlung von knochenkrankheiten. | |
| AR013001A1 (es) | Derivados de la piperazina, procedimientos para prepararlos, las composiciones farmaceuticas que los contienen, su utilizacion como medicamentoy el metodo para tratar enfermedades mediadas por la taquinina. | |
| BR0310087A (pt) | Veìculos sólidos injetáveis para ácido hialurÈnico para aplicação de proteìnas osteogênicas | |
| PE20000644A1 (es) | Combinaciones terapeuticas que comprenden un modulador del receptor de estrogenos selectivo y hormona paratiroidea | |
| BR0012951A (pt) | Agonistas de retinóides seletivos | |
| ECSP044961A (es) | Acido n-(5-clorosaliciloil)-8-aminocaprilico como agente de suministro oral para fragmentos de hormona paratiroides | |
| PE20000633A1 (es) | Combinaciones terapeuticas para la fragilidad musculoesqueletica | |
| IT1170214B (it) | Composizione farmaceutica per la cura delle arteriopatie periferiche | |
| AU2284001A (en) | Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone | |
| BRPI0409884A (pt) | compostos, composições farmacêuticas, método para o tratamento ou porfilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos | |
| BRPI0407178A (pt) | Composição farmacêutica osteogênica | |
| BRPI0409818A (pt) | compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos | |
| AR048672A1 (es) | Tabletas de desintegracion que comprenden licarbazepina | |
| PE20000646A1 (es) | Terapia de combinacion para la fragilidad musculoesqueletica | |
| BR0213878A (pt) | Processo para a formação de sólidos de ibuprofeno | |
| MXPA03010679A (es) | Una composicion para acelerar la cicatrizacion de fractura osea. | |
| PT1638582E (pt) | Uso de ácido hialurónico para a preparação de composições para o tratamento de aftas recorrentes da cavidade bucal | |
| BRPI0409881A (pt) | compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |